NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spearhead Bio

Spearhead Bio

Private
St. Louis, MissouriHealthcare & Life Scienceshttps://danforthtechnology.com/

Last Round

Seed Round

Jun 23, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Spearhead Bio is an agricultural biotechnology company that leads the next generation of native genome engineering tools to accelerate the development and launch of new transgenic & non-transgenic crops.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

genome engineeringTAHITIgene insertionagricultural biotechnologycrop improvementag-techgene editingTransposase Assisted Homology Independent Targeted Insertioncrop breedingtransposase technologyCRISPR complementplant sciencetrait stackingtransgenic cropsnon-transgenic crops

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spearhead Bio Comparables

Compare Spearhead Bio with similar companies based on industry and business-model similarity.

Spearhead Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Solis Agrosciences
83%
Demeetra AgBio
78%
Hudson River Biotechnology
76%

Spearhead Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 23, 2026
VC RoundJan 29, 2026
GrantJul 14, 2025
SeedMay 13, 2025

Spearhead Bio Investors

Notable investors and investment history

Spearhead Bio investors
InvestorRounds
Danforth Technology CompanyVC Round, Seed
BioGenerator VenturesVC Round, Seed
Helix FundSeed
National Science FoundationVC Round, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    $1.2M raised in Seed Round.

  • Jan 29, 2026

    $4M raised from BioGenerator Ventures and others.

Spearhead Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spearhead Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spearhead Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSt. Louis, Missouri
Year Founded2025
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.